Filter by tags

Why root-only ashwagandha matters: what the classical texts and modern research agree on

Key Takeaways

  • Ayurvedic classical texts specified the root of ashwagandha as the therapeutically active part; the leaves and stems were considered pharmacologically distinct and used for different purposes.
  • The root contains the plant's highest concentration of withanolides, the steroidal lactone compounds considered responsible for ashwagandha's adaptogenic and stress-modulating effects.
  • KSM-66 is a full-spectrum root extract standardized to at least 5% withanolides using a proprietary water-based process with no harsh chemical solvents involved.
  • Clinical trials on KSM-66 specifically have demonstrated reductions in cortisol, improvements in stress scores, and benefits for sleep, athletic performance, and cognitive function.
  • Whole-plant or leaf-heavy extracts are cheaper to produce but lack the same bioactive profile and are not backed by the same clinical evidence.
Why root-only ashwagandha matters: what the classical texts and modern research agree on

There is a version of the ashwagandha conversation that goes like this: ashwagandha is an adaptogen, it reduces stress, it comes in a capsule or a gummy, the end. That version is fine as far as it goes, which is not very far. It skips over the part where not all ashwagandha extracts are equivalent where the plant part used, the extraction method, and the standardisation of bioactive compounds determine whether what you are taking is genuinely effective or just carrying a name with a good reputation.

KSM-66 Ashwagandha Honey Sticks use a root-only extract specifically the KSM-66 form, which is the most clinically studied ashwagandha extract on the market. That is not a trivial detail. Why root-only matters is a story that starts in ancient India and ends in randomised controlled trials, and both sources are pointing in the same direction. Here is the full picture.


What Ayurveda actually said about ashwagandha and which part of the plant it was talking about

Ashwagandha (Withania somnifera) has been used in Ayurvedic medicine for over three thousand years. Its name translates as "smell of horse" a reference to the root's characteristic aroma and, in Ayurvedic tradition, an association with the vitality and strength of horses. It is classified as a Rasayana, meaning a substance that promotes systemic rejuvenation, longevity, and the restoration of ojas the fundamental vital energy that underlies physical and mental resilience.

What is often glossed over in modern discussions of ashwagandha is that the Charaka Samhita and Sushruta Samhita, the foundational texts of Ayurvedic medicine, were specific about which part of the plant they were describing. The root is the part consistently identified as therapeutically active in the Rasayana context. The leaves were used for specific topical and preparatory applications. The stem and other plant parts had their own, different uses. This was not arbitrary. Ayurvedic physicians were empirical observers who documented what worked, in what form, for what purpose, across centuries of clinical practice. The root specificity was a considered distinction.

Modern plant chemistry is explaining why that distinction was correct.


The chemistry of why the root is different from the rest of the plant

Ashwagandha's primary bioactive compounds are withanolides steroidal lactones that are found in highest concentration in the root. These are the compounds that most of the clinical research on ashwagandha's effects has focused on, because they are the primary candidates for the plant's adaptogenic, anti-inflammatory, and neuroprotective mechanisms.

The root also contains alkaloids (including isopelletierine and anaferine), iron, and other phytochemicals that contribute to the full-spectrum bioactive profile. The leaves contain a different withanolide profile including withaferin A in higher concentrations than the root which has different biological activity and is not the same as the withanolide profile that the HPA axis and stress-modulating research is based on.

When a supplement uses whole-plant ashwagandha which means leaves, stems, and other parts in addition to root the bioactive profile is diluted and altered. The withanolide concentration per gram drops. The proportion of leaf-derived compounds increases. The resulting extract does not reflect the chemistry that the classical texts were working with, nor the chemistry that modern clinical trials have studied. It is cheaper to produce, which is why it is used, but it is not equivalent.


What KSM-66 is and why the extraction method matters

KSM-66 is a trademarked, full-spectrum root extract of Withania somnifera developed by Ixoreal Biomed. "Full-spectrum" in this context means the extract preserves the natural ratio of bioactive compounds present in the root, rather than isolating a single compound. It is standardized to a minimum of 5% withanolides a defined, consistent concentration in every batch.

The extraction process is unusually clean. Most high-concentration botanical extracts are produced using alcohol or other chemical solvents to concentrate the bioactives. KSM-66 uses a water and milk-based extraction method specifically designed to avoid harsh solvents and to align with traditional Ayurvedic preparations, in which ashwagandha root was commonly processed with milk or ghee. This is not nostalgia. Certain ashwagandha compounds are lipophilic (fat-soluble), and traditional milk-based preparations may have facilitated their absorption in ways that water extraction alone does not. The KSM-66 process is designed to replicate the bioavailability of those traditional preparations while meeting modern manufacturing standards.

Every batch is third-party tested. The company maintains GRAS (Generally Recognized as Safe) status in the US, and KSM-66 has been used in over 24 clinical trials as the specific form studied.


What the clinical research on KSM-66 actually shows

Here is where the classical texts and modern science converge most clearly: the effects that Ayurvedic physicians observed and documented over centuries improved resilience to stress, better sleep quality, enhanced physical vitality, sharper cognition are the same outcomes showing up in randomised controlled trials on KSM-66.

A 2012 study published in the Indian Journal of Psychological Medicine found that 300mg of KSM-66 twice daily over 60 days produced significant reductions in serum cortisol and self-reported stress scores compared to placebo, with improvements in sleep quality and general wellbeing. A 2019 RCT published in Medicine found that KSM-66 supplementation in resistance-training men was associated with significantly greater increases in muscle strength, recovery, and testosterone levels alongside cortisol reductions. A study in the Journal of the International Society of Sports Nutrition found improvements in cardiorespiratory endurance and VO2 max. Research published in the Journal of Dietary Supplements found improvements in memory, attention, and information-processing speed.

These are not vague or marginal effects. They are consistent, dose-dependent, and replicated across multiple study populations. And they are specific to KSM-66 not to ashwagandha generally, and certainly not to the whole-plant extracts that make up the majority of the supplement market.


The honey stick format and why delivery method is part of the story

Ashwagandha root has a distinctive bitter, earthy flavour that has historically been managed in Ayurvedic preparations by combining it with honey, ghee, or milk substances that both masked the taste and, in the case of fats, may have supported the absorption of lipophilic compounds. Our KSM-66 Ashwagandha Honey Sticks deliver the root extract in raw honey, which is the closest contemporary equivalent to the classical preparation. No capsule to swallow. No awkward powder to dissolve. One honey stick, daily, in a format that Charaka would arguably have recognised.

GMP-certified. Third-party tested for withanolide content, purity, and heavy metal safety on every production batch. No artificial additives.

Frequently Asked Questions

The key differences are the plant part used (root only versus whole plant), the withanolide concentration (standardised at 5% minimum in KSM-66 versus inconsistent or unlisted in many standard products), the extraction method (clean water and milk-based process versus solvent extraction), and the clinical evidence base (over 24 specific trials on KSM-66 versus general ashwagandha research that used varying extracts). These are not marketing distinctions; they determine the actual bioactive profile you are getting.

Clinical trials on KSM-66 typically show meaningful results at eight to twelve weeks of consistent daily use. Stress and sleep improvements tend to appear earliest often within four to six weeks. Improvements in physical performance, cognitive function, and body composition measures take longer to accumulate because they reflect deeper shifts in the hormonal and cellular environment. Ashwagandha is not an acute stimulant with immediate effects. It is an adaptogen whose benefits build with consistent use.

KSM-66 at the doses used in clinical trials (300 to 600mg per day) has a well-established safety profile in healthy adults. Long-term safety has been studied at up to 90 days in multiple trials without adverse effects. As with any supplement, individuals on thyroid medications, immunosuppressants, or sedatives should consult a healthcare provider before use, as ashwagandha's HPA axis activity may interact with these.